Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $6.69 billion. The enterprise value is $6.41 billion.

Market Cap	6.69B
Enterprise Value	6.41B

Important Dates

The next estimated earnings date is Monday, March 16, 2026, after market close.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 37.51 million shares outstanding. The number of shares has increased by 8.68% in one year.

Current Share Class	n/a
Shares Outstanding	37.51M
Shares Change (YoY)	+8.68%
Shares Change (QoQ)	+1.96%
Owned by Insiders (%)	1.21%
Owned by Institutions (%)	6.78%
Float	17.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	22.70
P/TBV Ratio	24.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 34.37, with a Debt / Equity ratio of 0.00.

Current Ratio	34.37
Quick Ratio	34.17
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,379.40

Financial Efficiency

Return on equity (ROE) is -32.30% and return on invested capital (ROIC) is -21.84%.

Return on Equity (ROE)	-32.30%
Return on Assets (ROA)	-21.22%
Return on Invested Capital (ROIC)	-21.84%
Return on Capital Employed (ROCE)	-24.64%
Weighted Average Cost of Capital (WACC)	-3.78%
Revenue Per Employee	n/a
Profits Per Employee	-$2.50M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +207.15% in the last 52 weeks. The beta is -1.46, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.46
52-Week Price Change	+207.15%
50-Day Moving Average	156.46
200-Day Moving Average	93.41
Relative Strength Index (RSI)	64.30
Average Volume (20 Days)	247,037

Short Selling Information

Short Interest	391,677
Short Previous Month	329,748
Short % of Shares Out	1.96%
Short % of Float	n/a
Short Ratio (days to cover)	1.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-67.59M
Pretax Income	-62.39M
Net Income	-62.39M
EBITDA	-67.41M
EBIT	-67.59M
Earnings Per Share (EPS)	-$1.93

Full Income Statement

Balance Sheet

The company has $275.61 million in cash and $510,000 in debt, with a net cash position of $275.10 million or $7.33 per share.

Cash & Cash Equivalents	275.61M
Total Debt	510,000
Net Cash	275.10M
Net Cash Per Share	$7.33
Equity (Book Value)	274.08M
Book Value Per Share	7.86
Working Capital	269.15M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-31.20M
Capital Expenditures	n/a
Free Cash Flow	-31.20M
FCF Per Share	-$0.83

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.68%
Shareholder Yield	-8.68%
Earnings Yield	-0.93%
FCF Yield	-0.47%

Analyst Forecast

The average price target for Belite Bio is $161.57, which is -9.40% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$161.57
Price Target Difference	-9.40%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2